Company profile
Mabylon AG
Clinical-stage company engineering and developing antibody therapeutics in immunology, inflammation (I&I) and neurology
- Industry
- Biotechnology Research
- Employees
- 22
- Headquarters
- Schlieren
- Founded
- 2015
- Office locations
- 1
Mabylon AG company summary
Mabylon AG is a company in the Biotechnology Research industry, headquartered in Schlieren, founded in 2015. On LinkedIn the company has around 22 employees.
What technology does Mabylon AG use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About Mabylon AG
Mabylon AG, a clinical-stage biotech company, is leading innovation in antibody-based treatments for severe allergies, inflammation, and neurological disorders. Our B-cell screening platform rapidly identifies natural human antibodies with high specificity and therapeutic potential. MY006, our first-in-class multispecific antibody therapeutic for peanut allergy, is tackling the growing food allergy market.
Where is Mabylon AG located?
Mabylon AG lists 1 location.
Compare companies similar to Mabylon AG
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Mabylon AG mabylon.com | Biotechnology Research | 22 | 2015 | Schlieren |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about Mabylon AG
What does Mabylon AG do?
Mabylon AG, a clinical-stage biotech company, is leading innovation in antibody-based treatments for severe allergies, inflammation, and neurological disorders. Our B-cell screening platform rapidly identifies natural human antibodies with high specificity and therapeutic potential. MY006, our first-in-class multispecific antibody therapeutic for peanut allergy, is tackling the growing food allergy market.
How many employees does Mabylon AG have?
Mabylon AG has around 22 employees on LinkedIn.
Where is Mabylon AG headquartered?
Mabylon AG is headquartered in Schlieren.
When was Mabylon AG founded?
Mabylon AG was founded in 2015.
Build a lead list from companies like Mabylon AG
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.